Renocel 4000IU Injection

Renocel 4000 IU Injection is a recombinant human erythropoietin alfa therapy designed to stimulate red blood cell production in patients suffering from anemia. It is widely prescribed for anemia caused by chronic kidney disease, cancer chemotherapy, and HIV treatment. By improving hemoglobin levels, Renocel 4000 helps reduce the need for frequent blood transfusions, enhances oxygen supply to tissues, and supports patient recovery. The injection is administered under medical supervision via subcutaneous or intravenous routes.

Key Benefits

• Restores red blood cell count and improves hemoglobin levels.
• Reduces fatigue and enhances quality of life in anemic patients.
• Lowers dependency on blood transfusions, easing caregiver burden.
• Supports cardiovascular stability and reduces anemia-related complications.
• Improves adherence to primary therapies by enhancing patient resilience.

Therapeutic Indications

• Chemotherapy-induced anemia
• Chronic kidney disease

Renocel 4000 IU Injection contains Recombinant Human Erythropoietin Alfa (4000 IU/ml) as its active ingredient. This biosynthetic protein mimics the natural hormone erythropoietin, which regulates red blood cell production in the bone marrow. Renocel 4000 is widely used for anemia management in patients with renal impairment, chemotherapy-induced anemia, or HIV-related complications.

1. Locate & clean a 2-inch area around the injection site with an alcohol swab.
2. Prepare and unwrap the syringe, ensuring the needle is sterile.
3. Insert the needle into the vein at a 15–30° angle from the skin.
4. Withdraw the needle at the same angle and press a cotton ball over the site.

Note: Do not self-administer. This injection is strictly for use by healthcare professionals.

• Use only under prescription and medical supervision.
• Contraindicated in patients with hypertension, heart disease, or history of blood clots.
• Patients should avoid alcohol during treatment.
• Not recommended for pregnant or breastfeeding mothers.
• Store in a cool, dry place away from direct light and maintain cold-chain storage.

Q. What are the common storage challenges for Renocel 4000 IU Injection in hospital supply chains?
A. Hospitals must maintain cold-chain storage (2°C–8°C). Interruptions during transit or storage can compromise product stability and efficacy.

Q. Is bulk ordering available for Renocel 4000 injection via Medikabazaar’s B2B service?
A. Yes. Medikabazaar offers bulk procurement solutions with assured cold-chain logistics and supply consistency.

Q. Is Renocel 4000 IU Injection safe for pediatric and elderly patients?
A. Use depends on clinical assessment. Pediatric and geriatric patients may need adjusted dosing and close monitoring.

Q. How does Medikabazaar support order tracking and customer service for B2B buyers?
A. Medikabazaar provides real-time order tracking, dedicated account managers, and 24/7 customer support.

Q. Can Renocel 4000 IU Injection reduce the need for blood transfusions in anemia patients?
A. Yes. It stimulates red blood cell production, reducing transfusion dependency and hospital visits.